Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk

NACompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

April 15, 2024

Study Completion Date

April 15, 2024

Conditions
Diabetes Mellitus
Interventions
DEVICE

HBOT intervention

"HBOT is a treatment in which oxygen-enriched air (up to 100%) is administered to patients at a pressure.~HBOT intervention arm - 3 months of HBOT treatment, 9 months observation~all participants receive HBOT treatment for 3 months at year 2"

DEVICE

Sham intervention

"Sham was selected as the control condition rather than usual care to equate intervention groups with respect to other variables that could influence cognition and functional status, such as a new challenge (completing an activity program), peer socialization, and attention from staff."

Trial Locations (4)

10029

Icahn School of Medicine at Mount Sinai, New York

53076

University of Wisconsin, Madison

70300

Assaf HaRofeh Medical Center, Tzrifin

Unknown

Sheba Medical Center, Ramat Gan

All Listed Sponsors
collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Assaf-Harofeh Medical Center

OTHER_GOV

collaborator

University of Wisconsin, Madison

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03036254 - Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk | Biotech Hunter | Biotech Hunter